IO Biotech, Inc. (IOBTQ) Payables (2020 - 2025)
IO Biotech's (IOBTQ) quarterly Payables came in at $5.6 million in Q3 2025, up 6.3% YoY from $5.3 million in Q3 2024, and up 0.9% on a QoQ basis from $5.5 million in Q2 2025.
IO Biotech, Inc. (IOBTQ) Payables (2020 - 2025) Analysis & Trends
IO Biotech (IOBTQ) has 6 years of Payables data on file, last reported at $5.6 million in Q3 2025.
- Quarterly Payables rose 6.3% year-over-year to $5.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.6 million (up 6.3% YoY) and the FY2024 annual result came in at $4.7 million, up 20.19% from the prior year.
- Payables rose to $5.6 million in Q3 2025, from $5.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $6.6 million in Q3 2023 to a low of $2.1 million in Q1 2022.
- A 5-year average of $4.3 million and a median of $4.5 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables soared 652.49% — and 2024, when it slipped 20.9%.
- Tracing IOBTQ's Payables over 5 years: stood at $3.9 million in 2021, then rose by 1.93% to $4.0 million in 2022, then declined by 3.15% to $3.9 million in 2023, then climbed by 20.19% to $4.7 million in 2024, then climbed by 19.87% to $5.6 million in 2025.
- The last three Payables figures came in at $5.6 million (Q3 2025), $5.5 million (Q2 2025), and $5.2 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.59 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 4.66 Mn |
| Sep 30, 2024 | 5.26 Mn |
| Jun 30, 2024 | 5.02 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Sep 30, 2023 | 6.65 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 4.54 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | 2.17 Mn |
| Dec 31, 2020 | 522,000.00 |